Name

Cabozan­ti­nib

Syn­onyms

Carbozantinib;Cabozantinib(XL184Malate);Cabozantinib(XL184,BMS-907351);N-(4-(6,7-diMethoxyquinolin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxaMide(CAS£º849217-68-1);XL-186;N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N’-(4-fluorophenyl)-1,1-cyclopropanedicarboxamideCabozantinib(XL184,BMS-907351);1,1-cyclopropanedicarboxamide,n’-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-n-(4-fluorophenyl)-;Cabozantinib,

Mol­e­c­u­lar Formula

C28H24FN3O5

Mol­e­c­u­lar Weight

502

CAS Num­ber (Or Wat­son Num­ber for Non-CAS Products)

849217-68-1

EINECS

Appear­ance

Specs/​Standards

Enter­prise Stan­dard

Use

Links

This prod­uct is devel­oped by our R&D com­pa­ny Cam­ing Phar­ma­ceu­ti­cal Ltd (http://​www​.cam​ing​.com/), and here is the cor­re­spond­ing link http://​cam​ing​.com/​C​a​b​o​z​a​n​t​i​n​i​b​-​c​a​s​-​8​4​9​2​1​7​-​6​8​-1/

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you shortly. 

























    Please prove you are human by select­ing the truck.




    Dis­claimer

    This prod­uct is for research and devel­op­ment pur­pose only which may not be used direct­ly as drugs, food, cos­met­ics or for any oth­er non-R&D pur­pose. It may be tox­ic or haz­ardous, and should be han­dled only by qual­i­fied indi­vid­u­als trained in lab­o­ra­to­ry pro­ce­dures. The buy­er will be respon­si­ble to warn and inform any per­son that may be in con­tact with the prod­uct of the poten­tial risks and haz­ards, as well as to ensure that pur­chase, use and dis­pos­al of the prod­uct com­ply with local laws and regulations.